In the press

July 5, 2022

Einstein Hosts Inaugural Therapeutics Venture and Pitch Competition

Einstein Hosts Inaugural Therapeutics Venture and Pitch Competition

The following excerpt was taken from Einsteinmed.edu — continue reading here.

Scientists, venture investment firm leaders, and industry stakeholders gathered on Tuesday, June 7 to attend Albert Einstein College…

June 27, 2022—(BRONX, NY)—Scientists, venture investment firm leaders, and industry stakeholders gathered on Tuesday, June 7 to attend Albert Einstein College of Medicine’s inaugural Therapeutics Venture and Pitch Competition. The event, organized by Einstein’s office of biotechnology and business development, featured three research teams presenting their novel therapeutic approaches for potential investment and development. The day culminated in the announcement of the winning proposal, which was selected by representatives from the three biomedical and/or life science investment firms that co-sponsored the program: Orange Grove Bio, AlleyCorp, and Alexandria Venture Investments.

Related Press

October 6, 2021
IpiNovyx Bio closes $10 million seed financing round

IpiNovyx Bio closes $10 million seed financing round The below is an excerpt taken from EndPoints News about our portfolio company, Ipinovyx Bio. The following excerpt was taken from EndPonts News — continue reading here. “With a focus on autoimmune and inflammatory diseases, IpiNovyx Bio closed a $10 million seed financing round “With a focus… Continue reading IpiNovyx Bio closes $10 million seed financing round

March 23, 2023
Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships

Collaborations with Yonsei University Health System and Pohang University of Science and Technology Designed to Strengthen Biotech Entrepreneurial Ecosystem in South Korea The following excerpt was taken from Globenewswire– continue reading here. Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships CINCINNATI, March 23, 2023 (GLOBE NEWSWIRE) — Orange Grove Bio, a… Continue reading Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships

February 9, 2022
1819 Innovation Hub tenant inks key partnership with Korea VC firm

1819 Innovation Hub tenant inks key partnership with Korea VC firm The following excerpt was taken from TechOhio– continue reading here. A biotech firm that moved its headquarters from New York to Cincinnati in late 2021 has announced its first major collaboration A biotech firm that moved its headquarters from New York to Cincinnati in… Continue reading 1819 Innovation Hub tenant inks key partnership with Korea VC firm

February 25, 2021
Wall Street Journal

Wall Street Journal The following was taken from the Wall Street Journal. Check out the original piece here: https://www.wsj.com/articles/vc-daily-biotechs-test-new-company-building-model-11614261635 We are incredibly excited and humbled to be recognized in the Wall Street Journal for our innovative business model! We thank everyone who has been supporting us from the beginning. 

January 25, 2020
How to Invest in Biotech Series – Phases, Stages, and Pitfalls

Emily Whitehead was 5 years old when she was diagnosed with acute lymphoblastic leukemia… Her cancer was resistant to traditional treatments and her prognosis was poor. In a final effort to save their daughter, her parents enrolled her in a clinical trial study at Children’s Hospital of Philadelphia for a new type of therapy called… Continue reading How to Invest in Biotech Series – Phases, Stages, and Pitfalls

March 16, 2022
Orange Grove Bio and Cincinnati Children’s Hospital Medical Center Establish Collaboration

Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati

May 11, 2020
New Podcast Launched

We are ecstatic to announce that we have launched our new podcast “OGB Podcast” on both Spotify and Anchor. We will be talking to industry leaders about the state of the biotech industry as well as delving into the specifics of our guests expertise. You can find and listen to us on Spotify ( https://open.spotify.com/show/0tSRtB4tFUcqHhW43RkWIL… Continue reading New Podcast Launched

January 31, 2020
Michigan BioSocial

Michigan BioSocial Upcoming Webinar for Pre-Clinical Biotech Development Opportunities

September 29, 2020
Our first portfolio company, Asalyxa Bio, has launched

Our first portfolio company, Asalyxa Bio, has launched. The University of Michigan, our partner in the creation of this company, released a press release which can be read below. — Asalyxa Bio, a startup with neutrophil targeting drug-delivery technology invented at University of Michigan Asalyxa Bio, a startup with neutrophil targeting drug-delivery technology invented at… Continue reading Our first portfolio company, Asalyxa Bio, has launched

// Reset Post Data